The Clap Spimaco (2070) is set to launch a new factory, in partnership with the international company “AstraZeneca” for SAR 272 million to manufacture cancer and highly toxic drugs.
What The factory will extend over an area of 2,800 square meters, inside Spimaco’s factory in the Qassim region.
The factory’s annual production capacity will be more than 275 million treatment units.
So What Spimaco signed a memorandum of understanding with AstraZeneca to invest, transfer technology and manufacture a group of pharmaceuticals within the project of producing drugs for cancer diseases.
Now What Spimaco Pharmaceutical is a major player in the Saudi pharmaceutical sector and in other 16 other countries through its subsidiaries, providing reliable, high-quality pharmaceutical products.